Comparative efficacy of acellular pertussis vaccines: An analysis of recent trials

Pediatric Infectious Disease Journal

Volumn 16, Issue 4 SUPPL., 1997, Pages

  Cherry, James D ^a,b  

^a MATTEL CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

CLINICAL TRIAL; DRUG EFFICACY; DRUG RESEARCH; DRUG SCREENING; HUMAN; INFECTION PREVENTION; PERTUSSIS; PRIORITY JOURNAL; REVIEW; VACCINATION; WORLD HEALTH ORGANIZATION;

CHILD, PRESCHOOL; CLINICAL TRIALS; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; HUMANS; IMMUNIZATION SCHEDULE; INFANT; PERTUSSIS VACCINE; VACCINATION; VACCINES, COMBINED; WHOOPING COUGH;

EID: 0031003114     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199704001-00004     Document Type: Review

References (25)

1. Ad Hoc Group for the Study of Pertussis Vaccines. Placebo-controlled trial for two acellular pertussis vaccines in Sweden: protective efficacy and adverse events. Lancet 1988;1: 955-60.
2. Mortimer EA, Kumura M, Cherry JD, et al. Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children. Am J Dis Child 1990;144:899-904.
3. First International Pediatric Infectious Disease Conference, Monterey, CA, September 21 to 22, 1995.
4. Proceedings of the International Symposium on Pertussis Vaccine Trials. Rome, Italy, October 30 to November 1, 1995 (in press).
5. Trollfors B, Taranger J, Lagergård T, et al. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med 1995;333:1045-50.
6. Schmitt H-J, Wirsing von Konig CH, Neiss A, et al. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 1996;275:37-41.
7. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. N Engl J Med 1996;334:341-8.
8. Gustafsson L, Hollander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996;334:349-55.
9. The Göteborg Pertussis Vaccine Study. Clinical trials of a monocomponent pertussis toxoid vaccine (NICHD Ptxd): a technical report, 1995.
10. Efficacy Trial of Acellular Pertussis Vaccines. Technical Report Trial 1. Stockholm: Swedish Institute for Infectious Disease Control, 1995.
11. Kumura M, Kuno-Sakai H. Pertussis vaccines in Japan. Acta Paediatr Jpn 1988;30:143-53.
12. Klein DL. Multicenter acellular pertussis vaccine trial: a National Institutes of Health perspective. Pediatrics 1995;96: 547-8.
13. Issaacson J, Trollfors B, Taranger J, et al. Safety, immunogenicity and an open, retrospective study of efficacy of a monocomponent pertussis toxoid vaccine in infants. Pediatr Infect Dis 1994;13:22-7.
14. Edwards KM, Meade BD, Decker MD, et al. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 1995;96:548-57.
15. Decker MD, Edwards KM, Steinhoff MC, et al. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 1995;96:557-66.
16. Storsaeter J, Hallander H, Farrington CP, Olin P, Möllby R, Miller E. Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Vaccine 1990;8:457-61.
17. Storsaeter J, Blackwelder WC, Hallander HO. Pertussis antibodies, protection, and vaccine efficacy after household exposure. Am J Dis Child 1992;146:167-72.
18. Blackwelder WC, Storsaeter J, Olin P, Hallander HO. Acellular pertussis vaccines: efficacy and evaluation of clinical case definitions. Am J Dis Child 1991;145:1285-9.
19. Storsaeter J, Olin P. Relative efficacy of two acellular pertussis vaccines during three years of passive surveillance. Vaccine 1992;10:142-4.
20. Hallander HO, Storsaeter J, Möllby R. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. J Infect Dis 1991;163:1046-54.
21. WHO meeting on case definition of pertussis, Geneva, January 10 to 11, 1991. MIM/EPI/PERT/9.1. Geneva: WHO, 1991.
22. Heininger U, Cherry JD, Eckhardt T, Lorenz C, Christinson P. Clinical and laboratory diagnosis of pertussis in the regions of a large vaccine efficacy trial in Germany. Pediatr Infect Dis J 1993;12:504-9.
23. Cherry J. The common cold. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 3rd ed. Philadelphia: Saunders, 1992:137-42.
24. Wald E, Guerra N, Byers C. Upper respiratory infections in young children: duration of and frequency of complications. Pediatrics 1991;87:129-33.
25. Greco D, Slamaso S, Mastrantonio P, et al. A difference in relative efficacy of two DTaP vaccines in continued blinded-observation of children following a clinical trial. Pediatric Res 1996;39(No.4, Part 2):173A.